These benefits, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the strategy of targeting ACKR3 as a singular strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-similar disorders. Importantly, these receptors were being https://jamesa157tro0.wikinarration.com/user